Immune checkpoint inhibition in upper tract urothelial carcinoma.
Gianluigi CalifanoIdir OuzaidPaolo VerzeJean-Francois HermieuVincenzo MironeEvanguelos XylinasPublished in: World journal of urology (2020)
This review summarizes the main currently available evidence on the use of the PD-1/PD-L1 pathway inhibition with reference to patients presenting with UTUC.
Keyphrases